Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Rigel Pharmaceutical (RIGL)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 336,613
  • Shares Outstanding, K 166,640
  • Annual Sales, $ 4,480 K
  • Annual Income, $ -77,990 K
  • 36-Month Beta 1.43
  • Price/Sales 47.05
  • Price/Cash Flow N/A
  • Price/Book 3.38

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 7 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/18
See More
  • Average Estimate 0.04
  • Number of Estimates 4
  • High Estimate 0.04
  • Low Estimate 0.03
  • Prior Year -0.18
  • Growth Rate Est. (year over year) +122.22%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.96 +1.53%
on 12/26/18
2.49 -20.24%
on 01/07/19
-0.15 (-7.01%)
since 12/21/18
3-Month
1.96 +1.53%
on 12/26/18
3.29 -39.51%
on 11/07/18
-0.90 (-31.14%)
since 10/23/18
52-Week
1.96 +1.53%
on 12/26/18
4.68 -57.48%
on 04/12/18
-2.50 (-55.68%)
since 01/23/18

Most Recent Stories

More News
Rigel Pharmaceuticals Provides Business Update

Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today provided a business update, including the quantity of TAVALISSE(TM) bottles sold in 2018 and its cash position as of December 31, 2018, as well as an overview...

JPM : 102.42 (-0.51%)
RIGL : 1.99 (-1.49%)
Do Options Traders Know Something About Rigel Pharmaceuticals (RIGL) Stock We Don't?

Investors need to pay close attention to Rigel Pharmaceuticals (RIGL) stock based on the movements in the options market lately.

RIGL : 1.99 (-1.49%)
Rigel to Present at the 37th Annual J.P. Morgan Healthcare Conference

Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced that Raul Rodriguez, the company's president and CEO, is scheduled to present a company overview at the 37th Annual J.P. Morgan Healthcare Conference...

JPM : 102.42 (-0.51%)
RIGL : 1.99 (-1.49%)
Rigel to Present at the BMO Capital Markets 2018 Prescriptions for Success Healthcare Conference in New York City

Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced that Dean Schorno, the company's executive vice president and chief financial officer, is scheduled to present a company overview at the BMO Capital...

RIGL : 1.99 (-1.49%)
New Research Coverage Highlights Weight Watchers International, Rudolph Technologies, Lowe's Companies, Net 1 UEPS Technologies, Viasat, and Rigel Pharmaceuticals -- Consolidated Revenues, Company Growth, and Expectations for 2018

In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Weight Watchers International...

UEPS : 4.52 (-7.00%)
LOW : 90.82 (-0.81%)
RTEC : 20.30 (-0.34%)
VSAT : 60.86 (-0.94%)
RIGL : 1.99 (-1.49%)
WTW : 31.72 (-1.89%)
Implied Volatility Surging for Rigel Pharmaceuticals (RIGL) Stock Options

Investors need to pay close attention to Rigel Pharmaceuticals (RIGL) stock based on the movements in the options market lately.

RIGL : 1.99 (-1.49%)
Technological Advancements Show Growth in the Hospital Acquired Infection Control Market

According to data compiled by Mordor Intelligence, the Hospital Acquired Infection Control Market is expected to reach USD 33.78 Billion by 2021 and is growing at a CAGR of 8.3% during the forecasted....

AKAO : 1.26 (-2.33%)
SCYX : 0.74 (-2.63%)
RIGL : 1.99 (-1.49%)
PCTL : 0.1200 (-20.00%)
TTPH : 1.15 (-2.54%)
Rigel Pharmaceuticals (RIGL) Reports Q3 Loss, Tops Revenue Estimates

Rigel (RIGL) delivered earnings and revenue surprises of 12.50% and 38.41%, respectively, for the quarter ended September 2018. Do the numbers hold clues to what lies ahead for the stock?

RIGL : 1.99 (-1.49%)
Rigel: 3Q Earnings Snapshot

SOUTH SAN FRANCISCO, Calif. (AP) _ Rigel Pharmaceuticals Inc. (RIGL) on Tuesday reported a loss of $23.8 million in its third quarter.

RIGL : 1.99 (-1.49%)
Rigel Announces Third Quarter 2018 Financial Results and Provides Company Update

Rigel Pharmaceuticals, Inc. (Nasdaq:RIGL), today reported financial results for the third quarter ended September 30, 2018, and also provided an update on the commercial launch of TAVALISSE(TM) for treatment...

RIGL : 1.99 (-1.49%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 96% Sell with a Strongest short term outlook on maintaining the current direction.

Longer term, the trend strength is Maximum. Long term indicators fully support a continuation of the trend.

The market is in highly oversold territory. Beware of a trend reversal.

See More Share

Trade RIGL with:

Business Summary

Rigel Pharmaceuticals, Inc. is a clinical-stage drug development company that discovers and develops novel, small-molecule drugs for the treatment of inflammatory diseases, cancer and viral diseases. Its goal is to file one new investigative new drug application in a significant indication each year....

See More

Key Turning Points

2nd Resistance Point 2.16
1st Resistance Point 2.09
Last Price 1.99
1st Support Level 1.97
2nd Support Level 1.92

See More

52-Week High 4.68
Fibonacci 61.8% 3.64
Fibonacci 50% 3.32
Fibonacci 38.2% 3.00
Last Price 1.99
52-Week Low 1.96

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar